Showing results (371-380 of 414) with videos related to

Sort By:
Pageof 42
Histology and Histopathology|March 17, 2004
Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcomaP Ragazzini, G Gamberi, L Pazzaglia, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2001
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremityG Bacci, S Ferrari, A Tienghi, et al.
Hematological Oncology|March 11, 2009
A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03F Hitz, G Martinelli, E Zucca, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 16, 2006
Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institutionS Tonoli, F Bertoni, A De Stefani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Metalloproteinase expression and prognosis in soft tissue sarcomasM S Benassi, G Gamberi, G Magagnoli, et al.
AJNR. American Journal of Neuroradiology|April 4, 2015
Degree of Collaterals and Not Time Is the Determining Factor of Core Infarct Volume within 6 Hours of Stroke OnsetE Cheng-Ching, J A Frontera, S Man, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 1994
Airway eosinophilia in chronic bronchitis during exacerbationsM Saetta, A Di Stefano, P Maestrelli, et al.
Annali Italiani Di Chirurgia|January 1, 1996
[Role of lactose, arginine and lysine combination in fracture healing (an experimental study)]M Fini, R Giardino, N Nicoli Aldini, et al.
La Radiologia Medica|October 1, 1982
[Incidence of lymph node metastases in epithelial neoplasms of the oral cavity: risk factors]P Bacchini, E Barbieri, F Bertoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomasE Gaudio, C Tarantelli, I Kwee, et al.
Pageof 42